In summary, our results show that ACh promotes breast cancer cell proliferation and ERα activity, possibly in a ligand-independent manner through the MAPK/ERK signaling pathway, with consequences for the expression of EMT markers, suggesting its putative role in breast cancer progression. Here, ESR1 is linked to breast carcinoma.